特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

注入型ドラッグデリバリー - 世界市場の将来展望(2017-2026)

Injectable Drug Delivery - Global Market Outlook (2017-2026)

発行 Stratistics Market Research Consulting 商品コード 521402
出版日 ページ情報 英文 173 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.61円で換算しております。
注入型ドラッグデリバリー - 世界市場の将来展望(2017-2026) Injectable Drug Delivery - Global Market Outlook (2017-2026)
出版日: 2018年08月01日 ページ情報: 英文 173 Pages
概要

世界の注入型ドラッグデリバリー市場は2017年に4,041億4,000万米ドルとなりました。今後は12.8%のCAGRで拡大し、2026年には1兆1,998億9,000万米ドルに達すると予測されています。

当レポートでは、注入型ドラッグデリバリーの世界市場を調査し、市場の概要、タイプ、製剤容器、投与部位、用途、エンドユーザー、地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会の分析、競合情勢、主要企業のプロファイルなど包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 市場動向分析

  • イントロダクション
  • 成長要因
  • 阻害要因
  • 市場機会
  • 脅威
  • アプリケーション分析
  • エンドユーザー分析
  • 新興市場
  • 今後の市場のシナリオ

第4章 ファイブフォース分析

  • サプライヤーの交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入の脅威
  • 業界内での競争

第5章 注入型ドラッグデリバリー市場:タイプ別

  • イントロダクション
  • 製剤
    • 新規ドラッグデリバリー製剤
    • 従来型ドラッグデリバリー
    • 長時間作用型 (持続型) 注入製剤
  • デバイス
    • 従来型注入デバイス
    • 自己注射デバイス
    • 統合安全注射器
    • パッチインジェクター
    • 安全注射器
    • 皮下注入装置
    • その他

第6章 注入型ドラッグデリバリー市場:製剤容器別

  • イントロダクション
  • カートリッジ
  • アンプル
  • ボトル
  • 小瓶

第7章 注入型ドラッグデリバリー市場:使用パターン別

  • イントロダクション
  • 予防接種
  • 治療
  • その他

第8章 注入型ドラッグデリバリー市場:使用施設別

  • イントロダクション
  • 在宅医療現場
  • 病院・診療所
  • その他

第9章 注入型ドラッグデリバリー市場:投与部位別

  • イントロダクション
  • 循環/筋骨格(静脈内、心臓内、筋肉内、腹膜内)
  • 皮膚(皮内および皮下)
  • 中枢神経系(大脳内およびクモ膜下)
  • 臓器(硝子体内および関節内)

第10章 注入型ドラッグデリバリー市場:用途別

  • イントロダクション
  • ホルモン障害
    • 貧血
    • 抗血栓症/血栓溶解療法
    • 成長ホルモン欠乏症(GHD)
    • 糖尿病
    • 骨粗鬆症
    • リプロダクティブヘルス疾患
  • 自己免疫疾患
    • 多発性硬化症(MS)
    • 乾癬
    • リウマチ性関節炎
    • クローン病
    • その他
  • 希少疾患
  • 心血管疾患
  • 神経障害性中毒
  • 呼吸器疾患
  • 再生医療
  • 腫瘍学
  • その他
    • 美容治療
    • 疼痛管理
    • 血友病
    • C型肝炎
    • アレルギー

第11章 注入型ドラッグデリバリー市場:流通チャネル別

  • イントロダクション
  • 小売薬局
  • 病院
  • E-コマース

第12章 注入型ドラッグデリバリー市場:エンドユーザー別

  • イントロダクション
  • 外来ケア
  • 在宅
  • 病院・診療所
  • その他

第13章 注入型ドラッグデリバリー市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他

第14章 市場の主な動向

  • 合意、パートナーシップ、提携、合弁事業
  • 買収と合併
  • 新製品の発売
  • 拡大戦略
  • その他の主要戦略

第15章 企業プロファイル

  • Baxter International, Inc.
  • ELI Lilly and Company
  • Terumo Corporation
  • Becton, Dickinson and Company
  • Pfizer, Inc.
  • Gerresheimer AG
  • Teva Pharmaceutical Industries Ltd.
  • Schott AG
  • Sandoz
  • Antares Pharma, Inc.,
  • Zogenix, Inc.
  • Scandinavian Health Limited
  • Terumo Medical Corp.,
  • Ypsomed Holding AG
  • Unilife Corporation,
  • Vetter Pharma-Fertigung GmbH & Co. KG.
  • Nova Nordisk A/S
図表

List of Tables

  • Table 1 Global Injectable Drug Delivery Market Outlook, By Region (2016-2026) ($MN)
  • Table 2 Global Injectable Drug Delivery Market Outlook, By Type (2016-2026) ($MN)
  • Table 3 Global Injectable Drug Delivery Market Outlook, By Formulations (2016-2026) ($MN)
  • Table 4 Global Injectable Drug Delivery Market Outlook, By Novel Drug Delivery Formulations (2016-2026) ($MN)
  • Table 5 Global Injectable Drug Delivery Market Outlook, By Conventional Drug Delivery Formulations (2016-2026) ($MN)
  • Table 6 Global Injectable Drug Delivery Market Outlook, By Long-Acting Injection Formulations (2016-2026) ($MN)
  • Table 7 Global Injectable Drug Delivery Market Outlook, By Devices (2016-2026) ($MN)
  • Table 8 Global Injectable Drug Delivery Market Outlook, By Conventional Injection Devices (2016-2026) ($MN)
  • Table 9 Global Injectable Drug Delivery Market Outlook, By Self-Injection Devices (2016-2026) ($MN)
  • Table 10 Global Injectable Drug Delivery Market Outlook, By Integrated safety syringes (2016-2026) ($MN)
  • Table 11 Global Injectable Drug Delivery Market Outlook, By Patch injectors (2016-2026) ($MN)
  • Table 12 Global Injectable Drug Delivery Market Outlook, By Safety Syringes (2016-2026) ($MN)
  • Table 13 Global Injectable Drug Delivery Market Outlook, By Subcutaneous infusion devices (2016-2026) ($MN)
  • Table 14 Global Injectable Drug Delivery Market Outlook, By Other Devices (2016-2026) ($MN)
  • Table 15 Global Injectable Drug Delivery Market Outlook, By Formulation Packaging (2016-2026) ($MN)
  • Table 16 Global Injectable Drug Delivery Market Outlook, By Cartridges (2016-2026) ($MN)
  • Table 17 Global Injectable Drug Delivery Market Outlook, By Ampules (2016-2026) ($MN)
  • Table 18 Global Injectable Drug Delivery Market Outlook, By Bottles (2016-2026) ($MN)
  • Table 19 Global Injectable Drug Delivery Market Outlook, By Vials (2016-2026) ($MN)
  • Table 20 Global Injectable Drug Delivery Market Outlook, By Usage Pattern (2016-2026) ($MN)
  • Table 21 Global Injectable Drug Delivery Market Outlook, By Immunization (2016-2026) ($MN)
  • Table 22 Global Injectable Drug Delivery Market Outlook, By Curative Care (2016-2026) ($MN)
  • Table 23 Global Injectable Drug Delivery Market Outlook, By Other Usage Patterns (2016-2026) ($MN)
  • Table 24 Global Injectable Drug Delivery Market Outlook, By Facility of Use (2016-2026) ($MN)
  • Table 25 Global Injectable Drug Delivery Market Outlook, By Home Care Settings (2016-2026) ($MN)
  • Table 26 Global Injectable Drug Delivery Market Outlook, By Hospitals and Clinics (2016-2026) ($MN)
  • Table 27 Global Injectable Drug Delivery Market Outlook, By Other Facilities of Use (2016-2026) ($MN)
  • Table 28 Global Injectable Drug Delivery Market Outlook, By Site of Administration (2016-2026) ($MN)
  • Table 29 Global Injectable Drug Delivery Market Outlook, By Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal) (2016-2026) ($MN)
  • Table 30 Global Injectable Drug Delivery Market Outlook, By Skin (Intradermal and Subcutaneous) (2016-2026) ($MN)
  • Table 31 Global Injectable Drug Delivery Market Outlook, By Central Nervous System (Intracerebral and Intrathecal) (2016-2026) ($MN)
  • Table 32 Global Injectable Drug Delivery Market Outlook, By Organs (Intravitreal and Intra-Articular) (2016-2026) ($MN)
  • Table 33 Global Injectable Drug Delivery Market Outlook, By Application (2016-2026) ($MN)
  • Table 34 Global Injectable Drug Delivery Market Outlook, By Hormonal Disorders (2016-2026) ($MN)
  • Table 35 Global Injectable Drug Delivery Market Outlook, By Anemia (2016-2026) ($MN)
  • Table 36 Global Injectable Drug Delivery Market Outlook, By Antithrombotic/Thrombolytic Therapy (2016-2026) ($MN)
  • Table 37 Global Injectable Drug Delivery Market Outlook, By Growth Hormone Deficiency (GHD) (2016-2026) ($MN)
  • Table 38 Global Injectable Drug Delivery Market Outlook, By Diabetes (2016-2026) ($MN)
  • Table 39 Global Injectable Drug Delivery Market Outlook, By Osteoporosis (2016-2026) ($MN)
  • Table 40 Global Injectable Drug Delivery Market Outlook, By Reproductive Health Disease (2016-2026) ($MN)
  • Table 41 Global Injectable Drug Delivery Market Outlook, By Autoimmune Diseases (2016-2026) ($MN)
  • Table 42 Global Injectable Drug Delivery Market Outlook, By Multiple Sclerosis (MS) (2016-2026) ($MN)
  • Table 43 Global Injectable Drug Delivery Market Outlook, By Psoriasis (2016-2026) ($MN)
  • Table 44 Global Injectable Drug Delivery Market Outlook, By Rheumatoid Arthritis (2016-2026) ($MN)
  • Table 45 Global Injectable Drug Delivery Market Outlook, By Crohn's Disease (2016-2026) ($MN)
  • Table 46 Global Injectable Drug Delivery Market Outlook, By Other Autoimmune Diseases (2016-2026) ($MN)
  • Table 47 Global Injectable Drug Delivery Market Outlook, By Cancer (2016-2026) ($MN)
  • Table 48 Global Injectable Drug Delivery Market Outlook, By Orphan Diseases (2016-2026) ($MN)
  • Table 49 Global Injectable Drug Delivery Market Outlook, By Cardiovascular diseases (2016-2026) ($MN)
  • Table 50 Global Injectable Drug Delivery Market Outlook, By Neurology Addiction (2016-2026) ($MN)
  • Table 51 Global Injectable Drug Delivery Market Outlook, By Respiratory Diseases (2016-2026) ($MN)
  • Table 52 Global Injectable Drug Delivery Market Outlook, By Regenerative Medicine (2016-2026) ($MN)
  • Table 53 Global Injectable Drug Delivery Market Outlook, By Oncology (2016-2026) ($MN)
  • Table 54 Global Injectable Drug Delivery Market Outlook, By Other Therapeutic Applications (2016-2026) ($MN)
  • Table 55 Global Injectable Drug Delivery Market Outlook, By Aesthetic Treatment (2016-2026) ($MN)
  • Table 56 Global Injectable Drug Delivery Market Outlook, By Pain Management (2016-2026) ($MN)
  • Table 57 Global Injectable Drug Delivery Market Outlook, By Hemophilia (2016-2026) ($MN)
  • Table 58 Global Injectable Drug Delivery Market Outlook, By Hepatitis C (2016-2026) ($MN)
  • Table 59 Global Injectable Drug Delivery Market Outlook, By Allergies (2016-2026) ($MN)
  • Table 60 Global Injectable Drug Delivery Market Outlook, By Distribution Channel (2016-2026) ($MN)
  • Table 61 Global Injectable Drug Delivery Market Outlook, By Retail Pharmacy Stores (2016-2026) ($MN)
  • Table 62 Global Injectable Drug Delivery Market Outlook, By Hospitals (2016-2026) ($MN)
  • Table 63 Global Injectable Drug Delivery Market Outlook, By E-Commerce (2016-2026) ($MN)
  • Table 64 Global Injectable Drug Delivery Market Outlook, By End User (2016-2026) ($MN)
  • Table 65 Global Injectable Drug Delivery Market Outlook, By Ambulatory Care (2016-2026) ($MN)
  • Table 66 Global Injectable Drug Delivery Market Outlook, By Home Based (2016-2026) ($MN)
  • Table 67 Global Injectable Drug Delivery Market Outlook, By Clinics/Physician Offices (2016-2026) ($MN)
  • Table 68 Global Injectable Drug Delivery Market Outlook, By Other End Users (2016-2026) ($MN)

Note: Regional tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are presented in similar manner as the above.

目次

According to Stratistics MRC, the Global Injectable Drug Delivery market is expected to grow from $404.14 billion in 2017 to reach $1199.89 billion by 2026 with a CAGR of 12.8%. Increasing prevalence of chronic diseases, expansion in the biologics market and technological advances in the form of nanotechnologies are some of the factors propelling the market growth. However, growing injuries and the infections caused by needles is hampering the market growth.

Drug delivery is the method of administering a pharmaceutical compound into the body through different routes to achieve a therapeutic effect. Oral, injection-based, transdermal, and carrier-based are some of the types of drug delivery devices. Injectable drug delivery facilitates the rapid transport of a drug into the body by passing first-pass metabolism. It also helps in administering drugs in unconscious and comatose patients. It is used in conditions such as hormonal imbalance, cystic fibrosis, autoimmune diseases, pain, Wilson's disease, hemophilia, hepatitis C and ribose-5-phosphate isomerase deficiency.

Based on formulation packaging, Ampules segment has a significant growth in the market owing to its good barrier properties as compared to other types of packaging. In addition they offer better protection at a lesser cost, ease of transportation and low costs of manufacturing are the factors driving the market in this segment.

By Geography, North America was estimated to be the largest share for the market during the forecast period. The growth is attributed to the rising dominance of chronic diseases and the number of companies that are focused on collaboration and partnerships to ensure the availability of high-value products.

Some of the key players in the Injectable Drug Delivery market include Baxter International, Inc., ELI Lilly and Company, Terumo Corporation, Becton, Dickinson and Company, Pfizer, Inc., Gerresheimer AG, Teva Pharmaceutical Industries Ltd., Schott AG, Sandoz, Antares Pharma, Inc., Zogenix, Inc., Scandinavian Health Limited, Terumo Medical Corp., Ypsomed Holding AG, Unilife Corporation, Vetter Pharma-Fertigung GmbH & Co. KG and Nova Nordisk A/S.

Types Covered:

  • Formulations
  • Devices

Formulation Packagings Covered:

  • Cartridges
  • Ampules
  • Bottles
  • Vials

Usage Patterns Covered:

  • Immunization
  • Curative Care
  • Other Usage Patterns

Facility of Uses Covered:

  • Home Care Settings
  • Hospitals and Clinics
  • Other Facilities of Use

Site of Administrations Covered:

  • Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
  • Skin (Intradermal and Subcutaneous)
  • Central Nervous System (Intracerebral and Intrathecal)
  • Organs (Intravitreal and Intra-Articular)

Applications Covered:

  • Hormonal Disorders
  • Autoimmune Diseases
  • Cancer
  • Orphan Diseases
  • Cardiovascular diseases
  • Neurology Addiction
  • Respiratory Diseases
  • Regenerative Medicine
  • Oncology
  • Other Therapeutic Applications

Distribution Channels Covered:

  • Retail Pharmacy Stores
  • Hospitals
  • E-Commerce

End Users Covered:

  • Ambulatory Care
  • Home Based
  • Clinics/Physician Offices
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends.
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements.

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Injectable Drug Delivery Market, By Type

  • 5.1 Introduction
  • 5.2 Formulations
    • 5.2.1 Novel Drug Delivery Formulations
      • 5.2.1.1 Microparticles
      • 5.2.1.1.1 Microcapsules
      • 5.2.1.1.2 Microspheres
      • 5.2.1.2 Colloidal Dispersions
      • 5.2.1.2.1 Polymeric/Mixed Micelles
      • 5.2.1.2.2 Niosomes
      • 5.2.1.2.3 Liposomes
      • 5.2.1.2.4 Nanoparticles
      • 5.2.1.2.4.1 Nanoemulsions
      • 5.2.1.2.4.2 Solid-Lipid Nanoparticles
      • 5.2.1.2.4.3 Nanosuspensions
    • 5.2.2 Conventional Drug Delivery Formulations
      • 5.2.2.1 Reconstituted/Lyophilized Formulations
      • 5.2.2.2 Emulsions
      • 5.2.2.3 Solutions
      • 5.2.2.4 Suspensions
    • 5.2.3 Long-Acting Injection Formulations
  • 5.3 Devices
    • 5.3.1 Conventional Injection Devices
      • 5.3.1.1 Material
      • 5.3.1.1.1 Plastic
      • 5.3.1.1.2 Glass
      • 5.3.1.2 Usability
      • 5.3.1.2.1 Disposable Injection Devices
      • 5.3.1.2.2 Reusable Injection Devices
      • 5.3.1.3 Product
      • 5.3.1.3.1 Prefilled Syringes
      • 5.3.1.3.2 Fillable Syringes
    • 5.3.2 Self-Injection Devices
      • 5.3.2.1 Needle-Free Injectors
      • 5.3.2.1.1 Technology
      • 5.3.2.1.1.1 Spring-Based Needle-Free Injectors
      • 5.3.2.1.1.2 Vibration-Based Needle-Free Injectors
      • 5.3.2.1.1.3 Jet-Based Needle-Free Injectors
      • 5.3.2.1.1.4 Laser-Powered Needle-Free Injectors
      • 5.3.2.1.2 Product
      • 5.3.2.1.2.1 Prefilled Needle-Free Injectors
      • 5.3.2.1.2.2 Fillable Needle-Free Injectors
      • 5.3.2.1.3 Usability
      • 5.3.2.1.3.1 Disposable Needle-Free Injectors
      • 5.3.2.1.3.2 Reusable Needle-Free Injectors
      • 5.3.2.2 Autoinjectors
      • 5.3.2.2.1 Design
      • 5.3.2.2.1.1 Customized Autoinjectors
      • 5.3.2.2.1.2 Standardized Autoinjectors
      • 5.3.2.2.2 Technology
      • 5.3.2.2.2.1 Manual Autoinjectors
      • 5.3.2.2.2.2 Automated Autoinjectors
      • 5.3.2.2.3 Product
      • 5.3.2.2.3.1 Prefilled Autoinjectors
      • 5.3.2.2.3.2 Fillable Autoinjectors
      • 5.3.2.2.4 Usability
      • 5.3.2.2.4.1 Disposable Autoinjectors
      • 5.3.2.2.4.2 Reusable Autoinjectors
      • 5.3.2.3 Pen Injectors
      • 5.3.2.3.1 Design
      • 5.3.2.3.1.1 Customized Pen Injectors
      • 5.3.2.3.1.2 Standard Pen Injectors
      • 5.3.2.3.2 Product
      • 5.3.2.3.2.1 Dual-Chambered Pen Injectors
      • 5.3.2.3.2.2 Single-Chambered Pen Injectors
      • 5.3.2.3.3 Usability
      • 5.3.2.3.3.1 Disposable Pen Injectors
      • 5.3.2.3.3.2 Reusable Pen Injectors
      • 5.3.2.4 Wearable Injectors
    • 5.3.3 Integrated safety syringes
    • 5.3.4 Patch injectors
    • 5.3.5 Safety Syringes
    • 5.3.6 Subcutaneous infusion devices
    • 5.3.7 Other Devices

6 Global Injectable Drug Delivery Market, By Formulation Packaging

  • 6.1 Introduction
  • 6.2 Cartridges
  • 6.3 Ampules
  • 6.4 Bottles
  • 6.5 Vials

7 Global Injectable Drug Delivery Market, By Usage Pattern

  • 7.1 Introduction
  • 7.2 Immunization
  • 7.3 Curative Care
  • 7.4 Other Usage Patterns

8 Global Injectable Drug Delivery Market, By Facility of Use

  • 8.1 Introduction
  • 8.2 Home Care Settings
  • 8.3 Hospitals and Clinics
  • 8.4 Other Facilities of Use

9 Global Injectable Drug Delivery Market, By Site of Administration

  • 9.1 Introduction
  • 9.2 Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
  • 9.3 Skin (Intradermal and Subcutaneous)
  • 9.4 Central Nervous System (Intracerebral and Intrathecal)
  • 9.5 Organs (Intravitreal and Intra-Articular)

10 Global Injectable Drug Delivery Market, By Application

  • 10.1 Introduction
  • 10.2 Hormonal Disorders
    • 10.2.1 Anemia
    • 10.2.2 Antithrombotic/Thrombolytic Therapy
    • 10.2.3 Growth Hormone Deficiency (GHD)
    • 10.2.4 Diabetes
    • 10.2.5 Osteoporosis
    • 10.2.6 Reproductive Health Disease
  • 10.3 Autoimmune Diseases
    • 10.3.1 Multiple Sclerosis (MS)
    • 10.3.2 Psoriasis
    • 10.3.3 Rheumatoid Arthritis
    • 10.3.4 Crohn's Disease
    • 10.3.5 Other Autoimmune Diseases
  • 10.4 Cancer
  • 10.5 Orphan Diseases
  • 10.6 Cardiovascular diseases
  • 10.7 Neurology Addiction
  • 10.8 Respiratory Diseases
  • 10.9 Regenerative Medicine
  • 10.10 Oncology
  • 10.11 Other Therapeutic Applications
    • 10.11.1 Aesthetic Treatment
    • 10.11.2 Pain Management
    • 10.11.3 Hemophilia
    • 10.11.4 Hepatitis C
    • 10.11.5 Allergies

11 Global Injectable Drug Delivery Market, By Distribution Channel

  • 11.1 Introduction
  • 11.2 Retail Pharmacy Stores
  • 11.3 Hospitals
  • 11.4 E-Commerce

12 Global Injectable Drug Delivery Market, By End User

  • 12.1 Introduction
  • 12.2 Ambulatory Care
  • 12.3 Home Based
  • 12.4 Clinics/Physician Offices
  • 12.5 Other End Users

13 Global Injectable Drug Delivery Market, By Geography

  • 13.1 Introduction
  • 13.2 North America
    • 13.2.1 US
    • 13.2.2 Canada
    • 13.2.3 Mexico
  • 13.3 Europe
    • 13.3.1 Germany
    • 13.3.2 UK
    • 13.3.3 Italy
    • 13.3.4 France
    • 13.3.5 Spain
    • 13.3.6 Rest of Europe
  • 13.4 Asia Pacific
    • 13.4.1 Japan
    • 13.4.2 China
    • 13.4.3 India
    • 13.4.4 Australia
    • 13.4.5 New Zealand
    • 13.4.6 South Korea
    • 13.4.7 Rest of Asia Pacific
  • 13.5 South America
    • 13.5.1 Argentina
    • 13.5.2 Brazil
    • 13.5.3 Chile
    • 13.5.4 Rest of South America
  • 13.6 Middle East & Africa
    • 13.6.1 Saudi Arabia
    • 13.6.2 UAE
    • 13.6.3 Qatar
    • 13.6.4 South Africa
    • 13.6.5 Rest of Middle East & Africa

14 Key Developments

  • 14.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 14.2 Acquisitions & Mergers
  • 14.3 New Product Launch
  • 14.4 Expansions
  • 14.5 Other Key Strategies

15 Company Profiling

  • 15.1 Baxter International, Inc.
  • 15.2 ELI Lilly and Company
  • 15.3 Terumo Corporation
  • 15.4 Becton, Dickinson and Company
  • 15.5 Pfizer, Inc.
  • 15.6 Gerresheimer AG
  • 15.7 Teva Pharmaceutical Industries Ltd.
  • 15.8 Schott AG
  • 15.9 Sandoz
  • 15.1 Antares Pharma, Inc.,
  • 15.11 Zogenix, Inc.
  • 15.12 Scandinavian Health Limited
  • 15.13 Terumo Medical Corp.,
  • 15.14 Ypsomed Holding AG
  • 15.15 Unilife Corporation,
  • 15.16 Vetter Pharma-Fertigung GmbH & Co. KG.
  • 15.17 Nova Nordisk A/S